Bruker Stock
Bruker Corporation
Company data
- Sector
- Healthcare
- Industry
- Medical - Devices
- Country
- United States
- CEO
- Frank H. Laukien
- Employees
- 11,085
- Market cap
- $8.3 B
- IPO
- 04/08/2000
Bruker Corporation is a US company that operates as a global developer and manufacturer of scientific instruments and analytical diagnostic solutions. Headquartered in Billerica, Massachusetts, the company serves various market segments, ranging from life sciences and nanotechnology to superconducting materials for…
AI-generated company profile based on the figures on this page, last updated on 01/10/2026. Not investment advice.
Bruker stock: price history
1D
-3.1%
1W
-6.9%
1M
-9.7%
6M
+34.6%
YTD
+16.3%
1Y
+43.5%
2Y
-10.6%
5Y
-29.0%
10Y
+152.9%
Next earnings date
Next earnings date
02/11/2026 (in 16 days)
Volatility around earnings
~43% stronger price swings than usual
Bruker stock scores
- Valuation
Visible after free registration
- Trend
Visible after free registration
- Quality
Visible after free registration
- Dividend
Visible after free registration
- Growth
Visible after free registration
- Insider
Visible after free registration
- Earnings
Visible after free registration
- Revisions
Visible after free registration
- Sentiment
Visible after free registration
- Short Pressure
Visible after free registration
Register for free
Unlock all 11 scores
- 5 credits free on registration
- Access to virtual portfolios and watchlist
- No credit card, no payment details needed
- No subscription, no minimum term
- Our own servers in Germany, no US cloud
Deterministically calculated from financial metrics, not investment advice. Updated nightly, last on 17/10/2026.
Business model & megatrends
Robust business model that benefits noticeably from at least one megatrend.
1 more assignment (Enabler/Second row) Pro-only.
Bruker Corporation is a global developer and manufacturer of highly specialized scientific instruments as well as analytical and diagnostic solutions. The business model encompasses three technological focus areas: Life Science with systems for mass spectrometry and molecular diagnostics, nanotechnology (e.g., atomic force microscopy) as well as the Energy/Supercon Technologies segment for superconducting materials. In addition to selling complex hardware such as X-ray systems, the company offers specialized diagnostic consumables, such as PCR technologies for pathogen identification, and professional services. Through technological specialization in highly complex niche markets for research and process control, the company holds a strong market position.
- Revenue model
- Transactional
- Recurring revenue
- High
- Pricing power
- Strong
- Moat
- None
- Moat type
- None
- Capital intensity
- High
- Customer concentration
- Unknown
Ask the agents about Bruker
Analyst assessment of Bruker
PRICE TARGET LOW
US$50.00
CONSENSUS
US$67.00
MEDIAN
US$70.00
PRICE TARGET HIGH
US$80.00
0
STRONG BUY
16
BUY
15
HOLD
2
SELL
0
STRONG SELL
33
TOTAL · Buy
As of: 14/10/2026
Bruker stock metrics
P/E
-78.4
P/B
3.47
EV/EBITDA
40.69
RETURN ON EQUITY
-2.2%
NET MARGIN
-6.2%
DEBT/EQUITY
0.8
DIVIDEND YIELD
0.4%
AS OF
30/06/2026
Free float & liquidity
FREE FLOAT
68.1%
FLOAT SHARES
103,686,609
AVG. DAILY VOLUME (30D)
2,302,359
Insider transactions (SEC)
Munch Mark
Munch Mark
LAUKIEN FRANK H
Pusch Wolfgang
Pusch Wolfgang
Attention
Price since yesterday: -3.1%
Search (Google Trends)
Institutional holders
Dividends
Comparable stocks
Frequently asked questions about Bruker stock
What does Bruker do?
Bruker Corporation is a company in the Healthcare sector, Medical - Devices industry, headquartered in United States.
The CEO is Frank H. Laukien, the company employs around 11,085 people.
The IPO was on 04/08/2000; the stock trades on NASDAQ under the ticker BRKR.
What do analysts say about Bruker stock?
33 analysts rate the stock, the consensus is Buy (as of 14/10/2026).
The average price target is US$67.00, ranging from US$50.00 to US$80.00, with a median of US$70.00.
This is an external assessment, not a statement by Market Jury.
When does Bruker report next?
The next earnings date is 02/11/2026.
Around past earnings, price swings were roughly 43% stronger than usual.
Does Bruker pay a dividend?
Yes. The last dividend was US$0.05 per share, ex-date 21/09/2026, paid on 07/10/2026.
The dividend yield is 0.4% (as of 30/06/2026).
Which stocks are comparable to Bruker?
Comparable stocks include Abbott Laboratories, Stryker, Boston Scientific, Edwards Lifesciences, DexCom, GE HealthCare Technologies, Zimmer Biomet Holdings and Align Technology.
How can I get Bruker stock analyzed?
Clicking "Analyze stock" lets five strategies assess Bruker against fixed, published rules and judge it bullish, neutral or bearish. The jury states where it disagrees. A free account starts with 5 credits, a quick check costs 1 credit, a full analysis 2 credits.
Not investment advice. Past performance is not an indicator of future results.